10:04 AM EST - Khiron Life Sciences Corp. : Provided a corporate update on its global medical cannabis operations, including accelerating growth of 450% in its Colombian medical cannabis prescriptions, first sales in the U.K., and entry into the Peruvian market. Khiron reaches more than 3,500 medical cannabis prescriptions filled. Medical cannabis prescriptions increased by over 450% in Q3, compared to Q2 of 2020. Khiron's clinics exceeded 9,000 monthly patient consultations in September, marking a return to pre-pandemic monthly levels, supported by the launch of telehealth consultations. Khiron Life Sciences Corp.
shares V.KHRN are trading up $0.04 at $0.47.
